Diagnostic Imaging Devices - Malaysia

The projected revenue in the Diagnostic Imaging Devices market market in Malaysia is estimated to reach US$370.80m by 2024.
It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 6.05%, leading to a market volume of US$497.30m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$11.93bn in 2024.
The demand for advanced diagnostic imaging devices in Malaysia is rapidly increasing due to the country's growing healthcare industry.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Malaysia is experiencing significant growth and development due to various factors.

Customer preferences: Customers in Malaysia are increasingly demanding advanced and innovative diagnostic imaging devices that offer high-quality imaging and accurate results. They prioritize devices that are user-friendly, efficient, and provide quick diagnoses. Additionally, there is a growing preference for portable and handheld imaging devices that can be easily transported and used in remote areas or during emergencies.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Malaysia is the adoption of digital imaging technology. Digital imaging devices offer several advantages over traditional film-based devices, such as faster image acquisition, enhanced image quality, and the ability to store and share images electronically. This trend is driven by the increasing need for efficient and streamlined healthcare processes, as well as the growing availability of digital infrastructure in the country. Another trend in the market is the rising demand for point-of-care imaging devices. Point-of-care imaging devices allow for immediate on-site diagnosis, eliminating the need for patients to travel to imaging centers or hospitals. This trend is driven by the desire to improve patient outcomes and reduce healthcare costs by enabling early detection and intervention.

Local special circumstances: One of the unique circumstances in Malaysia is the government's focus on improving healthcare infrastructure and services. The government has implemented various initiatives to enhance healthcare accessibility and quality, including the development of new hospitals and clinics, as well as the expansion of existing healthcare facilities. This has created a favorable environment for the growth of the Diagnostic Imaging Devices market, as healthcare providers are investing in advanced imaging technologies to meet the increasing demand for diagnostic services.

Underlying macroeconomic factors: The growing population in Malaysia, coupled with the increasing prevalence of chronic diseases, is driving the demand for diagnostic imaging devices. As the population ages and the incidence of chronic diseases such as cardiovascular diseases and cancer rises, there is a greater need for accurate and timely diagnoses. This, in turn, is fueling the demand for diagnostic imaging devices. Furthermore, the rising disposable income and improving healthcare infrastructure in Malaysia are contributing to the growth of the Diagnostic Imaging Devices market. As individuals have more disposable income, they are willing to invest in advanced healthcare services and technologies, including diagnostic imaging devices. Additionally, the government's commitment to improving healthcare services and infrastructure is creating opportunities for market players to expand their presence in the country. In conclusion, the Diagnostic Imaging Devices market in Malaysia is experiencing significant growth and development due to customer preferences for advanced and innovative devices, the adoption of digital imaging technology, the demand for point-of-care devices, the government's focus on improving healthcare infrastructure, and the underlying macroeconomic factors such as the growing population and rising disposable income.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.